Paul Cuddon
Stock Analyst at Deutsche Bank
(3.43)
# 2,256
Out of 4,423 analysts
21
Total ratings
55.6%
Success rate
14.2%
Average return
Main Sectors:
Stocks Rated by Paul Cuddon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 210p → 225p | $116.50 | +93.13% | 6 | Jan 22, 2026 | |
| LON: SYNC Syncona Limited | Maintained: Buy | 170p | $96.00 | n/a | 1 | Jun 20, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Maintained: Buy | 2,750p → 3,100p | $1,457.00 | n/a | 3 | Nov 25, 2024 | |
| MXCT MaxCyte | Upgraded: Buy | $4.43 → $6.71 | $1.21 | n/a | 2 | Oct 10, 2024 | |
| LON: OXB Oxford Biomedica plc | Maintained: Hold | 250p → 380p | $600.00 | n/a | 2 | Sep 24, 2024 | |
| AIM: UPR Uniphar plc | Reiterated: Buy | 310p | $402.00 | n/a | 2 | Sep 4, 2024 | |
| AIM: AVCT Avacta Group Plc | Initiated Coverage: Hold | 40p | $73.00 | n/a | 2 | Jun 19, 2024 | |
| AIM: NIOX NIOX Group Plc | Initiated Coverage: Hold | 250p | $57.60 | n/a | 1 | May 3, 2024 | |
| AIM: CREO Creo Medical Group PLC | Maintained: Buy | 80p | $13.50 | n/a | 1 | May 3, 2024 | |
| LON: IPO IP Group Plc | Initiated Coverage: Buy | 100p | $64.70 | n/a | 1 | May 3, 2024 |
Oxford Nanopore Technologies plc
Jan 22, 2026
Reiterated: Buy
Price Target: 210p → 225p
Current: $116.50
Upside: +93.13%
Syncona Limited
Jun 20, 2025
Maintained: Buy
Price Target: 170p
Current: $96.00
Upside: n/a
Hikma Pharmaceuticals PLC
Nov 25, 2024
Maintained: Buy
Price Target: 2,750p → 3,100p
Current: $1,457.00
Upside: n/a
MaxCyte
Oct 10, 2024
Upgraded: Buy
Price Target: $4.43 → $6.71
Current: $1.21
Upside: n/a
Oxford Biomedica plc
Sep 24, 2024
Maintained: Hold
Price Target: 250p → 380p
Current: $600.00
Upside: n/a
Uniphar plc
Sep 4, 2024
Reiterated: Buy
Price Target: 310p
Current: $402.00
Upside: n/a
Avacta Group Plc
Jun 19, 2024
Initiated Coverage: Hold
Price Target: 40p
Current: $73.00
Upside: n/a
NIOX Group Plc
May 3, 2024
Initiated Coverage: Hold
Price Target: 250p
Current: $57.60
Upside: n/a
Creo Medical Group PLC
May 3, 2024
Maintained: Buy
Price Target: 80p
Current: $13.50
Upside: n/a
IP Group Plc
May 3, 2024
Initiated Coverage: Buy
Price Target: 100p
Current: $64.70
Upside: n/a